Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

 

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium
J

Decade-Long Remissions of Leukemia Sustained by the Persistence of Activated CD4+ CAR T-Cells

By Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium FEATURING Jan Joseph Melenhorst
By Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium FEATURING Jan Joseph Melenhorst
0 views
September 9, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
Keynote and Plenary Sessions
13:06
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Penn Medicine Q&A Panel on Cell Therapy During the COVID-19 Pand…

Feat. D. Porter, C. Bollard, G. Shah, S. Maude, S. Devine
29:34
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Penn Medicine Highlights on the Future of Cell and Gene Therapies fo…

Feat. C. June
09:10
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Penn Medicine Panel Discussion on Overcoming Resistance to Monothera…

Feat. S. Maude, N. Frey, M. Pule, D. Miklos
17:06
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Pediatric CAR T-Cell Therapy During COVID-19: CHOP Experience

Feat. S. Maude
50:17
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Penn Medicine Updates on Creating Smarter T Cells for Immunotherapy

Feat. S. Riddell
17:25
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

AUTO3 and Beyond: Experience With Co-targeting of CD19 and CD22 in D…

Feat. M. Pule
22:42
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Bispecific CAR19-22 and Sequential CAR22 Rescue: The Experience of a…

Feat. D. Miklos
08:58
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Developing CAR T-Cell Therapies in Brazil

Feat. R. Cunha
25:36
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Impact of COVID-19 on Recipients of HCT and CAR T-Cells

Feat. G. Shah
08:57
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Decade-Long Remissions of Leukemia Sustained by the Persistence of A…

Feat. J. Joseph Melenhorst
14:21
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Penn Medicine Q&A Discussion on CAR T-Cell Therapy in Hematologi…

Feat. R. Maziarz, T. Fry, A. Garfall, D. Maloney
14:40
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Penn Medicine Updates on CAR T-Cell Therapy for Lymphoma

Feat. D. Maloney
18:36
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Penn Medicine Updates on CAR T-Cell Therapy for Multiple Myeloma

Feat. A. Garfall
16:48
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

The Future of CAR T-Cell Therapy for ALL

Feat. T. Fry
14:38
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

CART22-65s Co-administered With huCART19 in Adult Patients With R/R …

Feat. N. Frey